about
Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of interventionPseudophakic cystoid macular edema associated with extrafoveal vitreoretinal traction.Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.Diabetic retinopathy: an updateOcular neovascularisation and excessive vascular permeability.Chronic macular edema associated with extrafoveal vitreoretinal traction.Spare the rod and spoil the eye.Correlation of Vascular Endothelial Growth Factor Production with Photochemical Reaction-induced Retinal Edema.Vascular endothelial growth factor in eye disease.Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown.Involvement of TonEBP/NFAT5 in osmoadaptative response of human retinal pigmented epithelial cells to hyperosmolar stress.Comparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema.Involvement of A(1) adenosine receptors in osmotic volume regulation of retinal glial cells in miceCombined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema.Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations.Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema.Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.Quantitative Analysis of Macular Thickness following Open Globe Injury in Subjects with Clear Media and no Retinal Damage.
P2860
Q28076321-6426169A-9717-4F89-869B-028609060B68Q30500692-40807B3B-4B75-41D2-9198-FD23126407BEQ33325652-2F53D7B4-A09A-4CFE-91A9-ACCC5D4574D2Q33328784-000710C7-748E-407C-A110-3BA81F62F523Q35873752-14FAE019-574F-49F6-A2A3-11296BDE633AQ35924000-15A4B30C-BCCC-4C6A-B4ED-6365F1EC3521Q36143737-1AB8E924-732B-48E7-92C8-74254D68F7D7Q36221472-DBBBA245-1215-46C0-8114-7F9E60002673Q36929380-E3DCA6A8-F7FA-4A86-9215-B31369A8B665Q37371699-955BF52D-0C3E-44D2-A534-2AA3F4F3ACE2Q38283375-297856DB-7807-47C9-A9FA-046647D1A8AAQ41545792-60CB7A9A-17F5-40A8-A73A-0527A176D498Q42555172-19F0C721-565F-4BD5-9EEF-F2910D5D632DQ43244106-34D0D0CA-E54E-4CA0-9F3B-58FC3653ACCDQ46770196-1CAEB0D7-D8BF-4D2D-B34D-1720C0EC2B93Q48094058-ED3C3142-14A0-409F-8E08-9BE73F6AE98CQ50223959-F531B62F-5244-483C-821C-7629FA5A42DCQ55250582-2EB97F51-B752-483C-B815-DEE3EF4F607C
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Macular oedema: the role of soluble mediators
@ast
Macular oedema: the role of soluble mediators
@en
type
label
Macular oedema: the role of soluble mediators
@ast
Macular oedema: the role of soluble mediators
@en
prefLabel
Macular oedema: the role of soluble mediators
@ast
Macular oedema: the role of soluble mediators
@en
P2093
P2860
P356
P1476
Macular oedema: the role of soluble mediators
@en
P2093
P A Campochiaro
S A Vinores
P2860
P304
P356
10.1136/BJO.84.5.542
P407
P577
2000-05-01T00:00:00Z